Pharmaceuticals
Novartis AG, GSK in $23-bn assets swap deal
22 Apr 2014
Swiss drug giant Novartis AG and Britain's GlaxoSmithKline Plc (GSK) today announced a swap of assets in a deal valued at around $23 billion
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn
22 Apr 2014
News of the impending bid sent the stock price of Valeant and Allergan companies soaring in after-hours trading
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Glenmark recalls anti-ulcer drug in the US over tablet mix-up
19 Apr 2014
Glenmark Pharmaceuticals Ltd is recalling 2,900 bottles of its anti-ulcer drug ranitidine from the US market after a tablet to treat high blood pressure was found in one of the bottles
After China, Iraq, Poland, GSK bribery probe now expands to Jordan, Lebanon
17 Apr 2014
The probe into a whistle-blower's allegations that British drug giant GlaxoSmithKline’s employees bribed doctors to prescribe its products has now expanded to the Middle East
.webp)
.webp)
